Phase I trial to evaluate safety, pharmacokinetics, and efficacy of sorafenib combined with docetaxel in patients with advanced, refractory solid tumors

被引：0
|
作者：
Awada, A.
Hendlisz, A.
Whenham, N.
Gil, T.
Christensen, O.
Lathia, C.
Bartholomeus, S.
Delabaye, I.
De Valeriola, D.
Brendel, E.
Delaunoit, T.
Piccart, M.
机构：
[1] Jules Bordet Inst, Brussels, Belgium
[2] Bayer Pharmaceut Corp, West Haven, CT USA
[3] Bayer HealthCare, Wuppertal, Germany
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [21] A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer
    I M E Desar
    J N H Timmer-Bonte
    D M Burger
    W T A van der Graaf
    C M L van Herpen
    British Journal of Cancer, 2010, 103 : 1637 - 1643
  • [22] A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer
    Desar, I. M. E.
    Timmer-Bonte, J. N. H.
    Burger, D. M.
    van der Graaf, W. T. A.
    van Herpen, C. M. L.
    BRITISH JOURNAL OF CANCER, 2010, 103 (11) : 1637 - 1643
  • [23] Pharmacokinetics and safety of sorafenib in combination with capecitabine in advanced solid tumors
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Bendell, Johanna C.
    Greco, F. Anthony
    Yardley, Denise A.
    Woudenberg, Janet
    Lathia, Chetan D.
    Lane, Cassie M.
    Spigel, David R.
    Hainsworth, John D.
    Burns, Howard A., III
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [24] Safety and pharmacokinetics of intravenous VEGF Trap in a phase I clinical trial of patients with advanced solid tumors.
    Dupont, J
    Rothenberg, ML
    Spriggs, DR
    Cedarbaum, JM
    Furfine, ES
    Cohen, DP
    Dancy, I
    Lee, HS
    Cooper, W
    Lockhart, AC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 199S - 199S
  • [25] Phase I trial to assess the safety and pharmacokinetics of afatinib and weekly vinorelbine in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Berge, Yann
    Massard, Christophe
    Uttenreuther-Fischer, Martina Maria
    De-Montserrat, Helene
    Tschoepe, Inga
    Soria, Jean-Charles
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Safety and Pharmacokinetics of Ganitumab (AMG 479) Combined with Sorafenib, Panitumumab, Erlotinib, or Gemcitabine in Patients with Advanced Solid Tumors
    Rosen, Lee S.
    Puzanov, Igor
    Friberg, Gregory
    Chan, Emily
    Hwang, Yuying C.
    Deng, Hongjie
    Gilbert, Jill
    Mahalingam, Devalingam
    McCaffery, Ian
    Michael, Shaunita A.
    Mita, Alain C.
    Mita, Monica M.
    Mulay, Marilyn
    Shubhakar, Poornima
    Zhu, Min
    Sarantopoulos, John
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3414 - 3427
  • [27] CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors.
    Spencer, Kristen Renee
    Mehnert, Janice M.
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Levinson, Kelly
    Stein, Mark N.
    Huzzy, Lien
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    DiPaola, Robert S.
    Chen, Suzie
    Wen, Yvonne
    Goydos, James
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Erich Brendel
    Matthias Ludwig
    Chetan Lathia
    Caroline Robert
    Stanislas Ropert
    Jean-Charles Soria
    Jean-Pierre Armand
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 53 - 61
  • [29] Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
    Brendel, Erich
    Ludwig, Matthias
    Lathia, Chetan
    Robert, Caroline
    Ropert, Stanislas
    Soria, Jean-Charles
    Armand, Jean-Pierre
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 53 - 61
  • [30] Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors
    Simonelli, Matteo
    Zucali, Paolo A.
    Lorenzi, Elena
    Rubino, Luca
    De Vincenzo, Fabio
    De Sanctis, Rita
    Perrino, Matteo
    Mancini, Luca
    Di Tommaso, Luca
    Rimassa, Lorenza
    Masci, Giovanna
    Zuradelli, Monica
    Suter, Matteo B.
    Bertossi, Monica
    Fattuzzo, Giuseppe
    Giordano, Laura
    Roncalli, Massimo G.
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (05) : 989 - 998
12345